BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 251.80
-0.40 (-0.16%)
Nov 11, 2026, 4:08 PM HKT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of 379.35 billion as of November 10, 2026. It is the 527th most valuable company in the world and the 26th biggest in Hong Kong. Its market cap has increased by 33.96% in one year.
Market Cap
379.35B
Enterprise Value
342.37B
Revenue
50.58B
Global Rank
Country Rank
#26 Hong Kong
PE Ratio
48.00
ChartMarket Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 6.70B to 379.35B, an increase of 5,564.60%. That is a compound annual growth rate of 45.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 379.35B | 44.97% |
| Dec 31, 2025 | 261.67B | 71.29% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 202.40B |
| Innovent Biologics | 152.16B |
| Sichuan Kelun-Biotech Biopharmaceutical | 111.34B |
| Sino Biopharmaceutical | 98.93B |
| Akeso | 84.75B |
| Genscript Biotech | 76.94B |
| RemeGen | 56.00B |
| Biocytogen Pharmaceuticals (Beijing) | 38.10B |